Bill Gruber is currently the President and CEO of Solace Therapeutics, an emerging women’s health company focused on a revolutionary non-surgical office based treatment for unexpected bladder leaks, the primary symptom of female Stress Urinary Incontinence (SUI). Bill was the President and CEO of Interlace Medical. While at Interlace he raised over $28MM in venture capital for the development and launch of devices for the treatment of Abnormal Uterine Bleeding caused by fibroids. The company was purchased by Hologic in 2011. Bill began his career in sales and marketing roles at Procter and Gamble before transitioning into the medical device sector. We discussed the types of urinary incontinence, what is the urethral sling, product design in FemTech and how to convince investors to care about women's health & wellness. Check out Solace Therapeutics at www.solacetx.com Rate, Review & Subscribe!